Literature DB >> 25545988

Development of aseptic subcutaneous abscess after tocilizumab therapy in a patient with SAPHO syndrome complicated by amyloid A amyloidosis.

Shunichi Fujita1, Nami Kosaka1, Takafumi Mito1, Hiroaki Hayashi2, Yoshitaka Morita1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25545988     DOI： 10.1111/1756-185X.12525

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN： 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  5 in total

Review 1.  SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment.

Authors:  Davide Firinu; Vanessa Garcia-Larsen; Paolo Emilio Manconi; Stefano R Del Giacco
Journal:  Curr Rheumatol Rep       Date:  2016-06       Impact factor: 4.592

Review 2.  Clinical heterogeneity of SAPHO syndrome: challenging diagnose and treatment.

Authors:  Francesco Cianci; Angelo Zoli; Elisa Gremese; Gianfranco Ferraccioli
Journal:  Clin Rheumatol       Date:  2017-07-19       Impact factor: 2.980

3.  Failure of tocilizumab in treating two patients with refractory SAPHO syndrome: a case report.

Authors:  Xiao-Chuan Sun; Shuang Liu; Chen Li; Shuo Zhang; Mu Wang; Xiao-Hua Shi; Wei-Xin Hao; Wen Zhang
Journal:  J Int Med Res       Date:  2018-11-14       Impact factor: 1.671

Review 4.  New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations.

Authors:  Wei Cheng; Fen Li; Jing Tian; Xi Xie; Jin-Wei Chen; Xiao-Fei Peng; Qi Tang; Yan Ge
Journal:  J Inflamm Res       Date:  2022-04-13

5.  Spinal cord dysfunction after COVID-19 infection.

Authors:  Gianluca Sampogna; Noemi Tessitore; Tatiana Bianconi; Alessandra Leo; Michele Zarbo; Emanuele Montanari; Michele Spinelli
Journal:  Spinal Cord Ser Cases       Date:  2020-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.